Brooklyn ImmunoTherapeutics (BTX) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free BTX Stock Alerts $1.93 -0.11 (-5.39%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 5:35 AM | americanbankingnews.comStockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)May 31, 2024 | americanbankingnews.comBrooklyn ImmunoTherapeutics (NYSE:BTX) Receives New Coverage from Analysts at StockNews.comDecember 19, 2023 | abcnews.go.com'Brooklyn Nine-Nine' star Andre Braugher dies at 61December 2, 2023 | nypost.comSabrina Carpenter blows off Catholic Church scandal: ‘Jesus was a carpenter’December 2, 2023 | travel.usnews.comBrooklyn BridgeNovember 8, 2023 | time.comBrooklyn Bedding Coupon for NovemberSeptember 28, 2023 | nypost.comDozens of vendors still swarm Brooklyn Bridge in free-for-all — selling illegal cocktails, pics with live snake: photosAugust 29, 2023 | mirror.co.ukBrooklyn Beckham's wife Nicola Peltz 'to be grilled on camera' over bitter wedding spatJune 29, 2023 | health.usnews.comBrooklyn Hospital CenterJune 22, 2023 | ft.comPure joy: the best of Brooklyn’s cool natural wine sceneJune 8, 2023 | forbes.comBest Moving Companies In Brooklyn, New York June 2023May 7, 2023 | usnews.comBrooklyn Technical High SchoolMay 6, 2023 | usnews.comBrooklyn Preparatory High SchoolMarch 31, 2023 | dailymail.co.ukBrooklyn Beckham: Latest news, views, gossip, photos and videoMarch 18, 2023 | mirror.co.ukBillionaire heiress Nicola Peltz and Brooklyn Beckham saving to buy their 'dream house'March 11, 2023 | mirror.co.ukVictoria Beckham 'fears for son Brooklyn and his wife Nicola' amid wedding lawsuitMarch 1, 2023 | nytimes.comIn Brooklyn, a Tiny Apartment and a Neighborhood Filled With FamiliesMarch 1, 2023 | nypost.comBrooklyn’s priciest rental of 2023 has quickly found a tenantFebruary 26, 2023 | cbsnews.comPolice ask for help identifying driver at the scene of shooting, carjacking in Brooklyn ParkFebruary 23, 2023 | foxnews.comBrooklyn Nets sign head coach Jacque Vaughn to multiyear contract extensionFebruary 19, 2023 | nytimes.comFor Strictly Observant Jews in Brooklyn, the Sabbath ExpandsFebruary 5, 2023 | yahoo.com7 Times Brooklyn Beckham Got Roasted for His Questionable Cooking SkillsJanuary 30, 2023 | dailymail.co.ukCruz Beckham teaches brother Brooklyn how to cook as he whips up a pizza on family outing in MiamiJanuary 28, 2023 | nypost.comLike Brooklyn Beckham, I’m a ‘one of the girls’ husband — and I love itNovember 12, 2022 | mirror.co.ukVictoria Beckham ignores Brooklyn and Nicola's anniversary posts as she teases book clubNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-QNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual MeetingNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Board ChangesNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Results of Phase 2 Study of IRX-2 in Head and Neck CancerNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Shares Tick lower After Data From Head and Neck Cancer StudyNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Name Change to Eterna Therapeutics and Provides Corporate UpdatesNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutic changing name to Eterna Therapeutics on MondayNovember 4, 2022 | finance.yahoo.comEterna Therapeutics Completes Name Change, Acquires Option to License iPSC-Derived NK and T Cell Therapies from Exacis BiotherapeuticsNovember 4, 2022 | finance.yahoo.comEterna Therapeutics to Present at iPSC-Derived Immunotherapies Congress Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Time is Running Out - June 25th Deadline Approaching! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. That will slam shut June 25. BTX Media Mentions By Week BTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BTX News Sentiment▼0.000.00▲Average Information News Sentiment BTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BTX Articles This Week▼10▲BTX Articles Average Week Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALFIW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BTX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored